Everything you need to know about the record CSL dividend

CSL's latest dividend is its biggest yet…

| More on:
Man holding out Australian dollar notes, symbolising dividends.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's been a bouncy but positive day for the S&P/ASX 200 Index (ASX: XJO) and many ASX 200 shares this Tuesday. After starting the week off on a strong footing yesterday, the ASX 200 is continuing that momentum today, with the index currently up 0.05%. But let's talk about what's happening with CSL Ltd (ASX: CSL) shares.

CSL shares are not faring as well as the broader market, to put it nicely. In fact, the ASX 200 healthcare giant is having an awful day.

Yesterday, the CSL share price closed at $308.93. But this morning, those same shares opened at just $300.03 and are currently trading at $296.37. That's down a hefty 4.07% for the day thus far.

It seems investors are not too impressed with the full-year earnings report that the company dropped this morning.

As we covered at the time, these earnings contained some fairly impressive figures. CSL reported an 11% bump in revenues for the 12 months to 30 June to US$14.8 billion.

That helped push the company's net profit after tax before amortisation (NPATA) up by 11% to US$2.91 billion, or up 15% to US$3.01 billion in constant currency terms.

As my Fool colleague covered after market open, it seems that investors may have been disappointed by CSL's guidance for FY2025. The company is expecting to record revenue growth of between 5-7% for the 12 months to 30 June 2025, and an NPATA of between US$3.2 and US$3.3 billion.

But let's talk about the supersized dividend that CSL has just revealed.

CSL ups its dividend to new record high

This morning, CSL revealed that its final dividend for FY2024 would come in at US$1.45 per share. That's a healthy 12.4% rise over the final dividend of US$1.29 ($2.01) per share that investors received last year, as well as a 21.85% increase over April's interim dividend of US$1.19 ($1.80) per share.

We don't yet know whether this latest payment will be in Australian dollars, but at today's exchange rates, US$1.45 would equate to approximately $2.20 per share. Like April's interim dividend, it will not come with any franking credits attached.

Nevertheless, this is a big deal for CSL, as this latest dividend represents a record-high shareholder payout for the company.

However, shareholders will have to wait a while until this passive income arrives in their bank accounts. CSL has scheduled Monday, 9 September next month as this payment's ex-dividend date. So anyone wishing to bag this payout will have to own CSL shares by market close on Friday, 6 September.

The payment date will then roll around on 2 October.

CSL's dividend reinvestment plan (DRP) is not operating for this payment, so shareholders have no other option than to receive a traditional cash payment.

At today's pricing, CSL shares have a trailing dividend yield of 1.28%. If we factor in the newly announced dividend, CSL would have a forward dividend yield of 1.35%.

Motley Fool contributor Sebastian Bowen has positions in CSL. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Three Archer Materials scientists wearing white coats and blue gloves dance together in their lab after making a discovery
Share Gainers

If I'd invested $8,000 in Pro Medicus shares 5 years ago I'd have $46,710 now!

Pro Medicus shares have delivered stellar five-year returns. But how?

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Is now the time to buy CSL shares after FY24 earnings?

The market was mixed after the biotech's results.

Read more »

A man slumps crankily over his morning coffee as it pours with rain outside.
Earnings Results

Cochlear shares sink 8% on FY24 earnings miss

The company's strong growth was not quite strong enough for the market.

Read more »

Woman presenting financial report on large screen in conference room.
Earnings Results

Cochlear share price on watch after reporting strong FY24 profit and dividend growth

This hearing solutions company delivered the goods over the 12 months.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

What's happening with the ResMed share price today?

Investors have become accustomed to ResMed shares outperforming in 2024. But what’s happening today?

Read more »

A man wearing glasses and a white t-shirt pumps his fists in the air looking excited and happy about the rising OBX share price
Healthcare Shares

Why is this ASX small cap ripping 37% ahead on Tuesday?

Big news is lifting this small cap to a record high today.

Read more »

Scientist looking at a laptop thinking about the share price performance.
Healthcare Shares

Why are ASX healthcare shares dragging on the ASX 200 today?

Healthcare stocks are dragging on the markets today, led by one in particular...

Read more »

Man with a sleep apnoea mask on whilst sleeping.
Healthcare Shares

3 reasons to buy Resmed shares like there's no tomorrow

The healthcare major continues to be well positioned, experts say.

Read more »